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Background: Methicillin-resistant staphylococci (MRS) are increasingly being isolated in bovine mastitis. The aim of
our study was to evaluate the occurrence of MRS in Finnish mastitis milk samples and characterize the MRS isolates
using molecular methods.
Results: Methicillin-resistant S. aureus (MRSA) was a rare finding in bovine mastitis in Finland. Only two out of 135
(1.5%) S. aureus isolates were positive for mec genes. One of these carried mecA and was of spa type t172, SCCmec
type IV and ST375, and the other harboured mecC, being spa type t3256, and ST130. MRSA ST375 is common
among human MRSA isolates in Finland, but this is the first report in the country of bovine mecC MRSA. In
coagulase-negative staphylococci (CoNS) originating from bovine mastitis, methicillin resistance was more common.
In the two CoNS collections studied, 5.2% (17/324) and 1.8% (2/110) of the isolates were mecA positive. Eighteen of
these were methicillin-resistant S. epidermidis (MRSE), which were divided into 6 separate PFGE clusters. One
pulsotype was detected in different parts of the country, indicating clonal spread. Most MRSE (13/18) were of
SCCmec type IV, one was of type V and four were non-typeable. Comparison with a human staphylococcal
database indicated that bovine MRSE strains were not closely related to human MRSE isolates.
Conclusions: The occurrence of MRS, especially MRSA, in bovine mastitis in Finland was low. Most methicillin-
resistant bovine CoNS are MRSE, and we found evidence of a bovine MRSE strain that may spread clonally. This is
the first report of a Finnish bovine isolate of MRSAmecC ST130. The study provides a baseline for further MRS
monitoring.
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Staphylococci are common etiological agents of bovine
mastitis. Infections caused by methicillin-resistant
staphylococci (MRS) are more difficult to treat and may
pose a public health risk [1]. Methicillin-resistant
Staphylococcus aureus (MRSA) was first reported in
cows in 1972, when Devriese and co-workers found 5.2%
of Belgian dairy farms MRSA positive [2]. Thirty years
later, MRSA became a sporadically reported finding
from bovine mastitis [3]. MRSA mainly spreads clonally.* Correspondence: veera.gindonis@helsinki.fi
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reproduction in any medium, provided the orSome MRSA isolates from bovine mastitis are thought
to be bovine and some of human origin [4,5]. Clonal
transmission between farmers and dairy cows has been
shown to occur [1]. More recently, livestock-associated
MRSA (LA-MRSA) strains of MRSA ST398 and strains
carrying MRSAmecC have emerged in humans [5-7].
These have also been isolated in bovine mastitis [5,8].
MRSA ST398 has been suggested to have developed in
humans as a methicillin-sensitive S. aureus (MSSA)
strain that was transferred to livestock, first to pigs and
then to cattle, and acquired the mecA gene [9].
MRSAmecC, however, was first found in both human and
bovine samples in 2011, and several different sequence
type lineages of MRSAmecC have been recognized [5,10].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(MR-CoNS) have also been isolated in bovine mastitis
[11-14]. They may be either species such as S.
epidermidis or S. haemolyticus, which are commonly en-
countered in both human and animal specimens, or spe-
cies that are mainly associated with bovine mastitis,
such as S. simulans or S. chromogenes [12,13]. In par-
ticular, methicillin-resistant S. epidermidis (MRSE) has
been a common finding: two recent studies from the
Netherlands and the USA reported that over 30% of S.
epidermidis isolated in bovine mastitis were MRSE
[13,14]. In a German study, eight out of 14 S.
epidermidis were MRSE [12]. There is evidence of clonal
transmission of MR-CoNS between humans and dairy
cows [15], and MRSE has been thought to spread clon-
ally within a herd of dairy cows [14].
Methicillin resistance in staphylococci is due to
penicillin-binding protein 2α (PBP2α), which is encoded
by mec genes. The mec genes are embedded in large mo-
bile elements called SCCmec (staphylococcal cassette
chromosome mec) [16], which also carry a cassette
chromosome recombinase (ccr) gene complex and J re-
gions (joining regions J1–J3) [17]. To date, 11 different
classes (I–XI) of SCCmec in MRSA have been reported,
and these are further divided into subtypes according to
variations in the J regions [18]. At least classes I–V and
XI of MRSA, and classes III–V of MR-CoNS, along with
several variants, have been isolated in bovine mastitis
[4,5,12,19-21]. MR-CoNS generally carry a vast variety of
SCCmec elements and are currently considered to be the
likely reservoir of the different types of mecA gene in
MRSA [22].Table 1 Collections of staphylococci isolated from bovine ma
Material Origin
Year
Isolate
n
1) S. aureus
isolates from the
Finnish Food
Safety Authority
(Evira)
Subclinical and clinical
mastitis cases nationwide.
2003–2008 135
2) CoNS isolates
from Bovine
Mastitis Survey
material
(Pitkälä et al., 2004)
Subclinical and clinical
mastitis, randomized
sample of a nationwide
bovine mastitis survey.
2001 324
3) CoNS isolates
from the
University
Ambulatory
Clinic** material
(Taponen et al.,
2006)
Subclinical and clinical
mastitis, on-call area of
the University Ambulatory
clinic.
1999–2002 110
* All isolates have been selected from the collections so that there is only one isola
** The Ambulatory Clinic of the Department of Production Animal Medicine, Faculty
*** The resistance breakpoints used for oxacillin were >2 μg/ml for bacterial collectThe aim of this study was to 1) estimate the occur-
rence of MRS in bovine mastitis in Finland, 2)
characterize the MRS isolates collected from bovine
mastitis, and 3) compare them with available human
isolates.
Methods
Bacterial isolates
To investigate the occurrence of methicillin resistance in
staphylococcal species isolated from bovine mastitis,
three sets of bacterial isolates were included in the study:
one collection of S. aureus (collection 1) and two collec-
tions of CoNS (collections 2 and 3) (Table 1). From each
collection, one isolate per staphylococcal species per
cow was included in the present study. In rare cases
where two or more isolates of the same species of the
same cow were available, the most resistant isolate was
chosen. All isolates were confirmed to be staphylococci
by their typical colonial appearance, a positive catalase
test and staining as Gram-positive cocci in clusters. Pre-
liminary differentiation between S. aureus and CoNS
was performed using a tube coagulase test (BD BBL
Rabbit Coagulase Plasma, Becton Dickinson, NJ, USA).
Antimicrobial susceptibility testing
Susceptibilities of the isolates were tested for penicil-
lin, oxacillin, tetracycline, erythromycin, clindamycin,
trimethoprim, chloramphenicol, vancomycin, gentami-
cin and ciprofloxacin by using a broth microdilution
method (VetMIC™, SVA, Sweden) according to the
existing standards [23,24]. Oxacillin results for
bacterial collection 2 were interpreted using astitis included in the study*
s Farms OxaMIC = R MRS
isolates
MRS-positive
farms MRS
species
n n (%)*** n (%) n (%)
117 18 (13.3) 2 (1.5) 2 (1.7) MRSA
179 34 (10.5) 17 (5.2) 16 (8.9) All MRSE,
2 isolates
originating
from the
same farm
57 6 (5.5) 2 (1.8) 2 (3.5) 1 MRSE
1 MR-S.
fleurettii
te per staphylococcal species per cow.
of Veterinary Medicine, University of Helsinki.
ions 1 and 2, and >1 μg/ml for collection 3 (see text for details).
Table 2 Characteristics of the methicillin-resistant S. epidermidis (MRSE) from bovine mastitis of the study (n = 18)
PFGE Cluster Isolate no. Oxacillin MIC
(μg/ml)*
Antimicrobial resistance profile* β-lactamase disk test BlaZ gene SCCmec type
(ccr type, mec class)
A 658 >4 PEN, OXA + + IV (2B)
B 1314 >4 PEN, OXA - + NT (2 -)
C1 1018 >4 PEN, OXA, TET, ERY + + IV (2B)
C1 1289 4 PEN, OXA, TET + + IV (2B)
C1 1439 4 PEN, OXA, TET, CHL + + IV (2B)
C1 1834 >4 PEN, OXA, TET + + IV (2B)
C1 2156 >4 PEN, OXA, TET + + IV (2B)
C1 28 VT >4 PEN, OXA, TET + + IV (2B)
C2 1532 >4 PEN, OXA, TET + + IV (2B)
C3 1391** 4 PEN, OXA, TET + + IV (2B)
C3 1409** 4 PEN, OXA, TET + + IV (2B)
C4 775 >4 PEN, OXA, TET + + V (5C2)
D1 641 4 PEN, OXA, TET + + IV (2B)
D1 1750 >4 PEN, OXA, TET - - IV (2B)
D2 990 >4 PEN, OXA, TET + + NT (2,5C2)
E1 9 2 PEN, OXA, TET, ERY + + NT (2,5B)
E2 1222 >4 PEN, OXA, TET, ERY + + NT (− −)
F 922 >4 PEN, OXA + + IV (2B)
Penicillin PEN, oxacillin OXA, tetracycline/oxytetracycline TET, erythromycin ERY, chloramphenicol CHL.
* Based on the results from Pitkälä et al. 2004 (Survey material), except for isolate 28 VT, which is from the Ambulatory Clinic material.
** Isolates originated from the same farm.
NT Non-typeable using the method described.
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EUCAST epidemiological breakpoints (www.eucast.
org) were applied to all other susceptibility test re-
sults. Beta-lactamase production by MRS isolates was
tested with Cefinase disks (BD BBL Paper Disk for the
Detection of β-Lactamase Enzymes, Becton-Dickinson,
NJ, USA).
Extraction of DNA
Chromosomal DNA for ribotyping and PCR was pre-
pared either using a previously described method [26]
or with the MasterPure Gram Positive DNA Purifica-
tion Kit (Epicentre Biotechnologies, Illumina Inc.,
Madison, WI, USA), High Pure PCR Template Prep-
aration Kit (Roche, Basel, Switzerland) or Easy-DNA
Kit (Invitrogen, Life Technologies, CA, USA).
Bacterial identification by nuc-PCR and ribotyping
Identification of MRSA isolates to the species level
was verified by PCR using primers specific for S. aur-
eus thermostable nuclease, the nuc gene [27]. MR-
CoNS isolates were analysed with the 16S and 23S
rRNA gene restriction fragment length polymorphism
method (ribotyping), as described previously [28], and
identified by comparison in a numerical similarityanalysis of the ribotype patterns with a ribotype li-
brary using the BioNumerics 4.6 software package
(Applied Maths, Kortrijk, Belgium).
Detection of mecA, mecC, blaZ and PVL genes by PCR
Staphylococci were tested for carriage of the mecA gene by
mecA PCR [29] with MRSA ATCC 29213 as a positive con-
trol. The selection criteria for mecA screening were set to
include all isolates exceeding the oxacillin resistance break-
point, and in addition, to include a representative number
other isolates, especially those having an oxacillin MIC near
the breakpoint. As a result, we included 63 S. aureus isolates
(collection 1): all isolates having oxacillin MIC ≥ 4 μg/ml
(n = 18); 80% of isolates having an oxacillin MIC of 2 μg/ml
(n = 36); and 9 isolates with low oxacillin MICs (≤ 1 μg/ml).
According to oxacillin histograms of the CoNS collections,
separation into susceptible and resistant populations was not
clearly evident. Therefore, from collection 2 we screened 238
CoNS isolates as follows: all isolates with MIC ≥ 4 μg/ml
(n = 34), as well as all isolates with MIC= 1–2 μg/ml (n = 200)
and 4 isolates with lower MICs. Collection 3 was smaller
and all CoNS isolates were therefore included for mecA
PCR (n= 110).
All mecA-negative S. aureus and mecA-negative CoNS
isolates with an oxacillin MIC of >2 μg/ml (n = 42) were
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ously described primers for a 138 bp PCR product [10].
MRSALGA251 was used as a positive control. The mecC
PCR reaction mixture contained 0.2 μM of both primers,
200 μM of each deoxynucleoside triphosphate, 1× buffer,
1U of polymerase (DyNAzyme DNA Polymerase Kit,
Finnzymes, Espoo, Finland), and 1 μl of DNA template in
a final volume of 50 μl. The PCR cycling conditions were
as follows: initial denaturation at 94°C for 5 min; 35 cycles
of denaturation at 94°C for 30 s, annealing at 58°C for
1 min, and elongation at 72°C for 1 min; and final elong-
ation at 72°C for 10 min. Positive mecC PCR results were
confirmed by sequencing of the PCR product at the Insti-
tute of Biotechnology, University of Helsinki. The se-
quence data were analysed with CLC Main Workbench
software (version 6.6.2, CLCbio, Aarhus, Denmark). All
mecA- or mecC-positive isolates were considered truly
methicillin resistant (MRSA or MR-CoNS) and were fur-
ther tested for the blaZ gene by a previously described
method [30]. S. aureus ATCC 29213 was used as a positive
control and S. aureus ATCC 25923 as a negative control
[31]. In addition, MRSA isolates were tested for the car-
riage of genes for Panton-Valentine leucocidin (PVL),
lukS-PV and lukF-PV [32].
SCCmec typing
The SCCmec types of isolates were assigned according
to two previously described multiplex PCRs, M-PCR1
and M-PCR2 [33], with slight modifications. M-PCR1
and M-PCR2 were carried out using 2U of DyNAzyme I
and 2U of DyNAzyme EXT DNA polymerases
(Finnzymes, Espoo, Finland), respectively. The amount
of DNA template was 200 ng in a final volume of 25 μl
in both multiplex PCRs. The following strains of S. aur-
eus were used as positive controls: NCTC 10442 (ccr1
and mec product B), ATCC BAA-1720 (ccr2, mec prod-
uct A), ATCC BAA-43 (ccr3), ATCC BAA-42 (ccr4) and
JCSC 6944 (ccr5, mec product C2).
Spa sequence typing and multilocus sequence typing
(MLST) of MRSA
The region encoding the Staphylococcus Protein A (spa)
was amplified as previously described [34]. The gene
product was sequenced and the repeat region was
analysed using BioNumerics (version 6.5, Applied Maths,
Belgium). MLST was performed as previously described
[35]. Sequencing results were compared against the
MLST database and the sequence types were determined
(http://www.mlst.net).
Pulsed-field gel electrophoresis
MRSE isolates were genotyped by PFGE using a previ-
ously described method [36] with slight modifications:
DNA fragments were separated on 1% agarose made in100 ml 0.5× TBE (casting frame 14 by 13 cm) by using a
Chef DR III system (Bio-Rad, USA) with 2000 ml of 0.5×
TBE as the running buffer. PFGE patterns were analysed
using Bionumerics software (version 5.10, Applied
Maths, Belgium). For interpretation, a similarity cut-off
of 80% and a difference of ≤6 in PFGE patterns were
used in assigning the isolates into clusters; identical pat-
terns were considered as the same pulsotype, and a dif-
ference of 3–6 bands as subtypes of the same cluster
[37]. The PFGE patterns of the bovine MRS isolates
were compared with the human staphylococcal culture
collection of the National Institute of Health and Wel-
fare (THL).Results
Two out of 135 S. aureus isolates originating from bo-
vine mastitis (1.5%) were MRSA, one isolated in 2005
and the other in 2006 from different herds. Both MRSA
strains had oxacillin MIC of >16 μg/ml. The MRSA
strain isolated in 2005 was of spa type t172, SCCmec
type IV, ST 375, which corresponds to the PFGE type
FIN-4 [37]. It carried the blaZ gene and was PVL nega-
tive. In addition to oxacillin the strain was phenotypi-
cally resistant to penicillin and trimethoprim, but
susceptible to other tested antimicrobials. The MRSA
strain isolated in 2006 carried mecC instead of mecA,
but was negative in blaZ PCR, although phenotypically
it produced beta-lactamase. This strain was highly sus-
ceptible to all tested antimicrobials except penicillin and
oxacillin. Sequencing verified the mecC PCR product to
be identical to the mecC of the MRSA LGA251 [5]. The
strain was of the ST130 and spa type t3256, and was
PVL negative. SCCmec of this strain was not recognised
by the used method.
Seventeen out of 324 (5.2%) CoNS isolates from the
national mastitis survey (bacterial collection 2) were
positive for mecA. All of them were ribotyped as S.
epidermidis. In this collection, 21.5% of all S. epidermidis
isolates (17/79) were MRSE. Based on the PFGE pattern
analysis, the strains of MRSE could be divided into three
clusters of 2, 10 and 3 isolates, and 3 singletons
(Figure 1). Twelve isolates were of SCCmec type IV and
one isolate was assigned to type V. Four isolates were
non-typable: two of them carried both ccr products 2
and 5, and the two other did not carry any mec products
recognized by the methods used. Five of the cluster 2
isolates were identical in PFGE (Figure 1), and they all
possessed the type IV SCCmec cassette. When compared
with human MRSE and MSSE (methicillin sensitive S.
epidermidis) strains, no similarity over 83.9% was
detected. In the samples collected at the Ambulatory
Clinic (bacterial collection 3), 2 out of 110 (1.8%) CoNS
were resistant to methicillin. The isolates were identified
Figure 1 PFGE patterns of the MRSE strains isolated from bovine mastitis in Finland.
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Altogether, nine S. epidermidis isolates were recognised
in collection 3. MRSE (isolate 28 VT in Figure 1 and
Table 2) was of SCCmec type IV and belonged to cluster
C. S. fleurettii was non-typeable by the SCCmec protocol
used.
No resistance to more than two classes of antimicrobials
(multiresistance) was detected in the bovine MRSA, but
four out of 18 MRSE of the study were multiresistant
(Table 2).
Discussion
The occurrence of MRSA in the present study was low,
totalling 1.6%. However, 5.2% and 1.8% of the investi-
gated CoNS isolates were mecA positive in bacterial col-
lections 2 and 3, respectively. On the farm level, MRS
occurred on 8.9% and 3.5% of the farms. These are
expected results, as MR-CoNS are more common than
MRSA [38]. In earlier studies, the occurrence of MRSA
(percentage of mecA-positive isolates out of all isolates
in the given S. aureus collection) from bovine mastitis
milk from Japan, Switzerland, Korea and Belgium has
been 1.1%, 1.4%, 1.6% and 9.3%, respectively [8,11,20,39].
The occurrence of MR-CoNS in previous studies has
been between 1.6 and 13.5% [11-14]. However, due to
methodological differences, comparison between the
studies is difficult.
The MRSA ST375 found in 2005 was of a type that is
frequently isolated in human specimens in Finland [40],
and it is likely to be of human origin. Human infectionsdue to MRSA ST375 are usually community acquired
and isolates of this clone are typically very susceptible to
other antimicrobials except betalactams. This was also
the case in our study. A follow-up study was performed
in 2008 in the same farm where ST375 was first detected
in 2005 (data not shown). Milk specimens as well as en-
vironmental specimens were collected. An identical
MRSA ST375 was again detected in one of the milk
specimens, but in addition, another MRSA strain was
discovered from a separate milk specimen. The latter
strain had the same spa type t172 as the previously iden-
tified MRSA ST375, but showed changes in the PFGE
pattern and was thus classified as a subtype of FIN-4 by
PFGE. Because in 2008 the cows on this farm were dif-
ferent from those sampled in 2005, the ST375 strain
detected in the cows could have originated from the
herd staff carrying the strain that evolved in them, and
might have been re-transmitted to the susceptible cows
over the years. Sampling of humans may have given add-
itional information to the epidemiology of MRSA on the
farm, but was not performed, as the people on the farm
rejected further evaluation.
The MRSAmecC t3256 ST130 found in the present
study is of the same spa type as two other mecC-
containing MRSA isolates from Denmark [10]. Our
strain was very susceptible to other antimicrobials,
which has been also a common finding in earlier reports.
MecC-carrying MRSA strains have also previously been
encountered in specimens from both humans and dairy
cows in UK, Ireland and France [5,7,10,41]. A recent
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long usually to two distinct clonal lineages, CC 130 and
CC 2361, but there are several distinct spa types [42].
Moreover, the results of the same study showed that hu-
man infections associated with mecC MRSA are usually
community acquired and often detected in humans liv-
ing in rural area. There is also strong evidence that
mecC MRSA is transmitted between ruminants and
humans [42,43]. The role of bovines and other rumi-
nants in the epidemiology of these MRSA lineages in
humans warrants further investigation. Sporadic cases of
human MRSAmecC have also been detected in Finland
(THL, unpublished data), but molecular typing results
were not yet available for comparison.
All but one of 19 MR-CoNS of the present study was
MRSE. The occurrence of MRSE among S. epidermidis
was lower than in previously published studies [12-14].
According to the PFGE results, the MRSE were assigned
into six different clusters (Figure 1). Five out of ten clus-
ter C isolates were identical in the PFGE, although they
originated from different parts of the country and no
common denominator could be seen. It seems possible
that this pulsotype spreads clonally. No close match was
found for the bovine strains of MRSE in the human
staphylococcal database of THL. However, there is no
continuous molecular surveillance of human MRSE, and
the database only covers genotypes from a limited num-
ber of isolates obtained from hospitalized patients. One
human MRSE isolate of the THL database had a similar-
ity of 83.9% with the cluster F singleton MRSE 922 of
the present study, and would therefore be classified as a
subtype of cluster F. S. epidermidis is a common cause
of hospital-acquired infections in humans, and the
hospital-acquired strains are mostly resistant to methicil-
lin [38]. Human isolates are often multiresistant,
whereas the strains found in this study were susceptible
to most classes of antimicrobials tested. This also sug-
gests that cattle and humans harbour different strains of
MRSE.
The SCCmec types IV and V found in the MRSE of
the present study are considered as community-acquired
SCCmec types in MRSA. Both types have previously
been encountered in bovine MRSE isolates [12,44]. It is
also common that MR-CoNS carry SCCmec elements
that are non-typeable by the established methods [22].
SCCmec types of bovine MRSE seem to have variation
like the isolates originating from humans [45], and bo-
vine MRSE may spread clonally between dairy farms the
same way as strains of MRSA and MRSE spread in
humans.
MRSA ST375 and most MRSE in this study (17/18)
carried the blaZ gene encoding beta-lactamase, causing
penicillin resistance. No blaZ gene was detected in the
MRSA ST130 carrying the mecC gene, although it wasphenotypically beta-lactamase positive. The most prob-
able reason for a negative result in blaZ PCR is that this
strain carries a divergent blaZ gene as described earlier
in S. aureus LGA 251 type strain or other strains belong-
ing to S. aureus clonal complex CC 130 with SCCmec
XI [5,7]. These studies reported that in this particular
SCCmec cassette the nucleotide sequences of the mec
and genes regulating its function, mecI and mecR1, as
well as sequences of the blaZ and ccr genes have many
differences compared to the respective genes carried by
other SCCmec types. For instance, similarities of diver-
gent blaZ gene sequence of the SCCmec XI are only be-
tween 44–68% at the protein level when compared to
other staphylococcal beta-lactamase genes at the
GenBank database (http://www.ncbi.nlm.nih.gov). The
blaZ gene primers used in this study are not able to de-
tect the blaZ gene variant of the SCCmec XI.
In many countries, mastitis is treated without bacterio-
logical diagnosis. Currently, almost 80% of milk speci-
mens from bovine mastitis in Finland are diagnosed by a
commercial PCR test that identifies the bacteria in the
specimen. For resistance, however, it only detects peni-
cillin resistance mediated by the blaZ gene. Therefore, it
is likely that cases of MRS mastitis mostly go unnoticed.
These can, in fact, be incorrectly reported as penicillin
susceptible, if staphylococci with divergent blaZ variant
will emerge and the primers of the test in question are
not covering the variant. Incorrect susceptibility infor-
mation can lead to inappropriate treatment strategy that
may, in part, select for already existing strains of MRS.
Treatment with cephalosporins but also with other beta-
lactams has been shown to select for MRSA in humans
[46]. These antibiotics are commonly used in dairy cows.
A reliable susceptibility testing method is therefore of
the utmost importance. National Finnish recommenda-
tions for MRSA of animal origin [47] state that cows
with MRSA should primarily be culled, the animal segre-
gated or the infected quarters dried off to stop the
MRSA from spreading to other cows and people. Methi-
cillin resistance is still rare in Finnish CoNS of bovine
origin, but MRSA-related management recommenda-
tions could also be applied to cows carrying MRSE. To
detect changes in methicillin resistance in bovine
staphylococci, regular national surveillance is needed.
Conclusions
The occurrence of MRS in dairy cows in Finland was
low. The results of this study can be used as a baseline
for further surveillance. According to our results, MRSE
is the most likely MRS in bovine mastitis, but MRSA is
expected to be a sporadic finding. MRSE can spread
clonally among the bovine population. Of the two
MRSA strains found in this study, MRSA ST375 is also
common among human MRSA isolates in Finland. This
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mecC gene in our country.
Staphylococci isolated in bovine mastitis should be
routinely tested for methicillin resistance. Surveys to re-
assess the situation should be conducted at regular inter-
vals for early intervention and the prevention of epidemic
strains from spreading in the population. Maintaining
low prevalence of MRS mastitis in Finland may succeed
through continuous education of veterinarians and
farmers on the importance of reliable susceptibility
testing, hygiene and judicious use of antibiotics.
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